These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17367304)

  • 21. Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.
    Tamborlane WV; Sikes KA; Steffen AT; Weinzimer SA
    Diabetes Res Clin Pract; 2006 Dec; 74 Suppl 2():S112-5. PubMed ID: 17182301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-reported outcomes and diabetes technology: a systematic review of the literature.
    Rubin RR; Peyrot M
    Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():405-12. PubMed ID: 20877254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
    Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
    Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous subcutaneous insulin infusion for managing diabetes: women's health implications.
    Hood DG
    Nurs Womens Health; 2012; 16(4):308-18. PubMed ID: 22900807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
    Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ
    Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes?
    Scheuing N; Badenhoop K; Borkenstein M; Konrad K; Lilienthal E; Laubner K; Naeke A; Rami-Merhar B; Thon A; Wiemann D; Holl RW;
    Pediatr Diabetes; 2015 Feb; 16(1):10-5. PubMed ID: 24984902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump].
    Schiffers T
    Psychother Psychosom Med Psychol; 1997 Jul; 47(7):249-54. PubMed ID: 9333836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin pump treatment of childhood type 1 diabetes.
    Weinzimer SA; Sikes KA; Steffen AT; Tamborlane WV
    Pediatr Clin North Am; 2005 Dec; 52(6):1677-88. PubMed ID: 16301088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rediscovery of insulin pump treatment of childhood type 1 diabetes.
    Weinzimer SA; Doyle EA; Steffen AT; Sikes KA; Tamborlane WV
    Minerva Med; 2004 Apr; 95(2):85-92. PubMed ID: 15272243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Education programmes for persons with type 1 diabetes using an insulin pump: A systematic review.
    Rytter K; Schmidt S; Rasmussen LN; Pedersen-Bjergaard U; Nørgaard K
    Diabetes Metab Res Rev; 2021 Jul; 37(5):e3412. PubMed ID: 33010190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin pump special eligibility criteria in New Zealand: a survey of prescriber opinion and practice.
    Groves M; Styles S; de Bock M
    N Z Med J; 2022 Apr; 135():82-88. PubMed ID: 35728187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of the science: A scoping review and gap analysis of adolescent insulin pump self-management.
    Faulds ER; Karnes L; Colicchio VD; Militello LK; Litchman M
    J Spec Pediatr Nurs; 2021 Oct; 26(4):e12331. PubMed ID: 33792146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: A critical interpretive synthesis.
    Reidy C; Bracher M; Foster C; Vassilev I; Rogers A
    Health Expect; 2018 Aug; 21(4):714-729. PubMed ID: 29418050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.